Domain Associates
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Headquarters Location
United States, San Diego
About
Domain Associates is the renowned VC, which was created in 1985. The main office of this VC is situated in San Diego. The VC's location is in North America, United States.
In comparison with other funds, Domain Associates makes 3 percentage points less than the average number of lead investments. We recorded the biggest number of exits for this fund in 2014. Deals in the range of 10 - 50 millions dollars are most common for this fund. In real terms, this VC performs 1 percentage points more exits than other funds. The fund typically enters into 7-12 deals annually. When Domain Associates invests, the average start-up valuation is 50-100 millions dollars. The fund's activity peaked in 2012. Besides, in 2019 the fund was active.
Besides the listed founders, we have found 9 key employees of this fund in our database.
Among their most successful investment fields, we have identified Health Diagnostics, Biotechnology. Also, because of its portfolio diversification tendency, we can highlight 15 more industries for this fund. Among the most popular portfolio start-ups of the fund, are Pharmion, Santarus, Tobira Therapeutics. The country of its foundation and the country of its most frequent investments coincides - United States. Besides this, the fund also invested in 4 other countries. The fund has an exact preference in the amount of founders of companies in its portfolio. When a start-up has 5+ founders, the probability of closing the deal is low. Also, a start-up has to be aged 4-5 years to expect investment from this fund.
The usual method for the fund is to invest in rounds with 4-5 other investors. Aside from Domain Associates, start-ups are often funded by Montreux Equity Partners, Johnson & Johnson Development Corporation, Venrock and 99 other funds. The fund often co-invests with Morgenthaler Ventures, Venrock, MPM Capital, overall with 178 funds from our list. The investors in the following rounds are usually Kleiner Perkins, Johnson & Johnson Development Corporation, Canaan Partners, and 121 VCs in total.
Year Founded
1985
Fund Activity
Operative
Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]
Domain name: domainvc.com; User name format in descending order of probability: first last, first, last, last first_initial, first last_initial
Group Appearance [how often fund is operating separately from groups with shared interest]
100.0% of cases
Investments per Year [average amount of rounds in which fund participates each year]
7-12
Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]
39.6% of cases
Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]
x7.9
Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]
4.1 years
Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]
0.44 out of 1
Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]
5
Funds Investing in Previous
Rounds
Montreux Equity Partners, Johnson & Johnson Development Corporation, Venrock
Funds Investing Together
Funds Investing in Following
Rounds
Kleiner Perkins, Johnson & Johnson Development Corporation, Canaan Partners
If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.
Unicorn Nest finds the most relevant investors for startups.
Tell us about your startup and get the list of VCs most likely to invest in your next round.
Find your perfect investor now
- No reviews are submitted yet.
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Complain
To post a comment or write a complain, please sign in with LinkedIn
